INTERACTION OF AZA ANALOGS OF CHLORPROMAZINE WITH THE DOPAMINE-D2 RECEPTOR

被引:5
|
作者
FAROOQUI, T [1 ]
MARKOVICH, K [1 ]
WALLACE, L [1 ]
MILLER, D [1 ]
URETSKY, N [1 ]
机构
[1] OHIO STATE UNIV,COLL PHARM,DIV PHARMACOL & MED,COLUMBUS,OH 43210
来源
GENERAL PHARMACOLOGY | 1993年 / 24卷 / 01期
关键词
D O I
10.1016/0306-3623(93)90026-T
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Permanently charged AZA analogs of chlorpromazine inhibited the binding of [H-3]spiperone and antagonized the apomorphine-induced inhibition of the potassium evoked release of [H-3]acetylcholine. 2. The AZA analogs were more potent in binding affinity and antagonist activity than the trimethylammonium analog of chlorpromazine but less potent than chlorpromazine. 3. These results suggest that it is possible to enhance the binding of the permanently charged trimethylammonium analog of chlorpromazine by the addition of a functional group near the quaternary nitrogen which is capable of forming a hydrogen bond with the D2 dopamine receptor. 4. However, it appears that for optimal binding, as achieved with chlorpromazine, the hydrogen-bonding proton should be on the charged nitrogen.
引用
收藏
页码:147 / 151
页数:5
相关论文
共 50 条
  • [1] THE INTERACTION OF AMMONIUM, SULFONIUM AND SULFIDE ANALOGS OF METOCLOPRAMIDE WITH THE DOPAMINE-D2 RECEPTOR
    HARROLD, MW
    SRIBURI, A
    MATSUMOTO, K
    MILLER, D
    FAROOQUI, T
    URETSKY, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 164 - MEDI
  • [2] INTERACTION OF PERMANENTLY CHARGED CHLORPROMAZINE AND DOPAMINE ANALOGS WITH THE STRIATAL D-1 DOPAMINERGIC RECEPTOR
    WALLACE, RA
    WALLACE, L
    HARROLD, M
    MILLER, D
    URETSKY, NJ
    BIOCHEMICAL PHARMACOLOGY, 1989, 38 (12) : 2019 - 2025
  • [3] AN ANTIBODY TO DOPAMINE-D2 RECEPTOR INHIBITS DOPAMINE ANTAGONIST AND AGONIST BINDING TO DOPAMINE-D2 RECEPTOR CDNA TRANSFECTED MOUSE FIBROBLAST CELLS
    FAROOQUI, SM
    PRASAD, C
    LIFE SCIENCES, 1992, 51 (19) : 1509 - 1516
  • [4] OPTIMIZATION OF BOVINE DOPAMINE-D2 RECEPTOR SOLUBILIZATION
    HOOPER, RJL
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (03) : 586 - 586
  • [5] EXPRESSION OF THE DOPAMINE-D2 RECEPTOR GENE IN BRAIN
    MEADORWOODRUFF, JH
    MANSOUR, A
    BIOLOGICAL PSYCHIATRY, 1991, 30 (10) : 985 - +
  • [6] PROPERTIES OF THE SOLUBLE BOVINE DOPAMINE-D2 RECEPTOR
    HOOPER, RJL
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (03) : 587 - 587
  • [7] STEREOELECTRONIC STUDY OF ZETIDOLINE, A DOPAMINE-D2 RECEPTOR ANTAGONIST
    COLLIN, S
    EVRARD, G
    VERCAUTEREN, DP
    DURANT, F
    CARRUPT, PA
    VANDEWATERBEEMD, H
    TESTA, B
    JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (01) : 38 - 42
  • [8] ANTIOXIDANTS PREVENT THE INTERACTION OF 3,4-DIHYDROXYPHENYLACETIC ACID AT THE DOPAMINE-D2 RECEPTOR
    CAMMACK, J
    TESSEL, R
    MICHAELIS, E
    ADAMS, RN
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 201 (01) : 111 - 113
  • [9] STRUCTURE OF THE RAT GENE ENCODING THE DOPAMINE-D2 RECEPTOR
    MARCHIONNI, MA
    GRANDY, DK
    ALFANO, M
    BUNZOW, JR
    CIVELLI, O
    JOURNAL OF GENERAL PHYSIOLOGY, 1989, 94 (06): : A22 - A22
  • [10] PET imaging of dopamine-D2 receptor internalization in schizophrenia
    J J Weinstein
    E van de Giessen
    R J Rosengard
    X Xu
    N Ojeil
    G Brucato
    R B Gil
    L S Kegeles
    M Laruelle
    M Slifstein
    A Abi-Dargham
    Molecular Psychiatry, 2018, 23 : 1506 - 1511